Preliminary results in a study of Apple Watch's ability to track heart data found 0.5%, or 2,161 people, received notifications of a potential irregular heartbeat an...

Eli Lilly's anti-angiogenic therapy Cyramza met the primary endpoint of a late-stage study, improving progression-free survival in previously untreated patients with...

On March 8, the FDA granted the accelerated approval of Roche’s programmed cell death protein 1 (PD-1) inhibitor Tecentriq in combination with Abraxane (protein-boun...

Even though the chronic kidney disease–mineral bone disorder (CKD-MBD) market is set to face several barriers to growth over the next decade, the anticipated launch ...

Researchers discover a drug that has the potential to stop sepsis before the condition reaches major organs and becomes fatal. A new preclinical trial of a sep...